Automated gene analyses of SARS-CoV-2 samples consistently miss gene segments in the virus genome that have undergone deletion due to
Study identifies Sars-CoV-2 variant with a deletion in its genome
Home ยป
Study finds increased risk for SARS-CoV-2 breakthrough infections in people with substance use disorders
An analysis of electronic health records of nearly 580,000 fully vaccinated people in the United States found that the risk
Study compares Pfizer and Moderna mRNA vaccine-elicited response to SARS-CoV-2 variants
The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious
Genetically engineered intestinal organoids reveal potential treatment targets against SARS-CoV-2
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2
Plant-based vaccine against SARS-CoV-2 shows promise
Researchers at Canadian biotechnology company Medicago report that Phase 1 trials of a plant-based vaccine for SARS-CoV-2 are underway and
Researchers study SARS-CoV-2 antibodies in asymptomatic and symptomatic individuals
MUSC Hollings Cancer Center researchers added to the understanding of the protective immune response against the SARS-CoV-2 virus in a
Triple mutation in SARS-CoV-2 seen in second wave of COVID-19 in India
Researchers sequenced the viral genome from samples in the state of Maharashtra and found a unique combination of three mutations
Neonates exposed to SARS-CoV-2 can sustain adverse health outcomes
The incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from mothers to newborns appears low and may be
Rapid mRNA vaccination effectively controls SARS-CoV-2 transmission in long-term care facilities
Vaccine rollouts all over the world are aimed at cutting short the coronavirus disease 2019 (COVID-19) pandemic by inducing antibody-mediated
Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting